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Introduction
Dendritic cells (DCs) are key players in the induction and maintenance of adaptive immunity. Interestingly, although the role of T and B lymphocytes in autoimmunity is well described in both humans and mice, (1) (2) (3) (4) and indeed biological agents targeting these cell lineages are currently used in the treatment of rheumatoid arthritis (RA) and systemic lupus erythematosus (5;6). far less is known about the specific involvement of DCs in autoimmune disease. In this respect, it is widely assumed that, because of the fundamental role of DCs in initiating T cell responses, DCs might play an essential pathological role in autoimmune disease by presenting self-antigens to autoreactive T cells. Primary immune responses are initiated in the periphery, where DCs capture and process antigens, increase expression of lymphocyte costimulatory molecules, migrate to lymphoid organs, and secrete cytokines that differentiate naïve T cells (7) .
It was shown that adoptive transfer of DCs pulsed with collagen type II (CII) was able to initiate experimental arthritis in mice (8) , thus showing the crucial role of these cells in the induction of arthritis. However, DCs not only activate lymphocytes, but are also capable of tolerising T cells to self or innocuous antigens, thereby minimising autoimmune reactions (9) . These dual functions of DCs depend on DC maturation status, cytokine profile and DC subset. DCs are a very heterogeneous population of cells, and different subsets can have very distinct functions. They are important in the breaching of self-tolerance in autoimmunity (10) , and plasmacytoid (p)DCs play an important anti-inflammatory role in the context of articular breach of tolerance (11) .
It was recently shown that compounds that selectively deplete DCs can ameliorate arthritis (12) and that blocking tyrosine kinases may have beneficial effects in arthritis by modulating DC numbers (13) . DCs can be efficiently differentiated in vitro by stimulating monocytes or haematopoietic progenitors with granulocyte macrophage colony-stimulating factor (GMCSF) (14;15) . Surprisingly, mice lacking GM-CSF or its receptor showed only a small decrease in lymphoid-organ DCs, with a maximum reduction of threefold in lymph node conventional/classical DCs (cDCs) and only a modest reduction in langerhans cells (LC), whereas GM-CSF transgenic mice showed reciprocal effects (16;17). Therefore, at least in the presence of compensatory cytokines, GM-CSF seemed to have little influence on steady-state DC maintenance, and it has been suggested that GM-CSF mostly contributes to inflammatory DC generation, potentially from monocytes, in vivo. It has been shown that Flt3L-and GM-CSF-derived DCs are phenotypically and also functionally different (34), and they can activate different T cell subsets in vivo and in vitro (28;34).
Flt3L accumulates in RA synovial fluid and induces arthritis when injected into healthy mouse knee joints. In addition, administration of Flt3L worsens experimental arthritis (35) . However, the exact mechanism by which Flt3L affects the development of arthritis remains unknown.
Here we took advantage of animals with targeted deletion of Flt3L to provide more insight into the role of Flt3L signalling in the pathogenesis of collagen-induced arthritis (CIA).
Material and methods
Animals
Male and female Flt3L −/− mice and WT littermates about 8-10 weeks old were used for the experiments. Further details are described in online supplementary methods.
Induction and assessment of CIA
We evaluated the role of Flt3L in CIA using Flt3L −/− and WT mice (n=10-15 per group). Mice were immunised as previously described. (36;37) Two independent experiments-acute (day 43) and chronic (day 60) stages-were performed. Further details are given in online supplementary methods.
Histological analysis
Hind paws were fixed for 24 h in 4% buffered formalin and decalcified in Osteosoft 
Statistical analysis
Areas under the curve for the change in arthritis scores were calculated. Incidence was compared using Kaplan-Meier survival analysis (GraphPad Prism V.5). The mean changes in scores (clinical, histological and immunohistochemical), total cell numbers, and cytokine-and collagen-specific IgG1 and IgG2a antibody levels between groups were determined by Mann-Whitney U test. p<0.05 was considered significant.
Results
Reduced incidence and severity of CIA in Flt3L-deficient mice
In agreement with the original description of these mice (33), mice lacking Flt3L developed normally and showed no gross anatomical defects or phenotypic abnormalities. Decreased cellular infiltration and cartilage degradation in Flt3L −/− mice in the chronic phase of the disease T cell responses during CIA in Flt3L −/− mice: reduced cytokine production, activation and costimulatory markers Total CD4 and CD8 T cell numbers and phenotype in inguinal and axillary LNs during the chronic phase of CIA on day 60 were assessed by FACS analysis. We observed a significant reduction in CD8 T cell numbers (figure 3A, p=0.0259) and a trend towards Reduced DC numbers and changes in DC subsets in Flt3L −/− mice during the acute phase of CIA
The half-life of mature DCs is short, and, since cytokine production is transient, the number and type of DCs present in the T cell areas will mirror the conditions of the tissues from which the lymph is drained (38) . To study the number and diversity of the 
CII-specific antibody production
It has previously been reported that expression of the inducible T cell costimulator Induction and assessment of CIA 
Histological analysis
Two independent observers assessed the tissue for the degree of synovitis and cartilage degradation by microscopic evaluation, under blinded conditions, as 
Measurement of antigen-specific antibodies and their affinity in serum
A 96-well plate was coated with cCII (5 μg/ml; Chondrex Inc. Redmond, WA) and incubated overnight at 4°C. Non-specific binding was blocked with phosphatebuffered saline containing 1% bovine serum albumin for 1 h at room temperature.
Serial dilutions of standard antibody solution (mouse anti-type II collagen IgG1 or IgG2a both 10 ng/ml, Chondrex) and serum samples were incubated for 1 h at room temperature, followed by the addition of horseradish peroxidase-conjugated rat anti-mouse IgG1 or IgG2a (BD Biosciences, San Jose, CA). After 1 h of incubation at room temperature, tetramethylbenzidine substrate was added and the optical density at 450/540 nm was measured using a microplate reader.
T cell proliferation in vitro antibodies. There were no differences in the amount of CII specific IgG1 and IgG2a antibodies at day 60.
